Skip to main content
. 2007 Dec;48(6):791–799. doi: 10.3325/cmj.2007.6.791

Table 1.

Baseline clinical characteristics (mean ± standard deviation) in patients receiving rosiglitazone, metformin, and no hypoglycemic treatment


Treatment with



Characteristic (years) rosiglitazone (n = 30) metformin (n = 30) control (n = 30) P*
Age
41.5 ± 11.4
42.1 ± 9.8
43.4 ± 10.9
0.782
Duration of HIV infection
8.4 ± 1.4
7.8 ± 2.7
6.0 ± 1.9
<0.001
Duration of treatment 3.4 ± 1.2 3.1 ± 2.1 2.8 ± 1.6 0.386

*One way ANOVA.